Home » Topics » BioWorld Science

BioWorld Science
RSS

New mutant EGFR inhibitors identified at Medshine Discovery

July 9, 2018

Laboratorios del Dr. Esteve discovers dual mu-opioid/sigma1R ligands

July 9, 2018

Dual GLP-1R/GCGR agonist may help to improve the control of postprandial glucose in type 2 diabetes

July 9, 2018

Hangzhou Innogate Pharma divulges protein kinase inhibitors

July 9, 2018

Leo Pharma presents phosphodiesterase PDE4 inhibitors

July 9, 2018

Orion initiates phase III REFALS study of oral levosimendan for the treatment of ALS

July 9, 2018

Fatty acid synthase inhibitors synthesized at Cephalon

July 9, 2018

mAChR antagonists/beta2-adrenoceptor agonists patented by Beijing Showby Pharmaceutical

July 9, 2018

Homozygous mutations in SLC10A7 gene linked to skeletal dysplasia

July 9, 2018

New missense variant in the FBXW11 gene associated with developmental eye and limb anomalies

July 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...